Levofloxacin Hemihydrate price index

Levofloxacin Hemihydrate price December 2025 and outlook (see chart below)

• India:US$24.02/KG, -7.5% down

Business Analytiq assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness, or timeliness.

Levofloxacin Hemihydrate price index

This post is a summary of the Levofloxacin Hemihydrate price developments. The price developments of Levofloxacin Hemihydrate are expressed in US$ prices converted FX rates applicable at the time when the price was valid. Levofloxacin Hemihydrate price index developments are calculated from multiple separate sources of data to ensure statistical accuracy.

The outlook for Levofloxacin Hemihydrate prices is generated from different inputs including:

• Very recent price developments of immediate cost drivers of Levofloxacin Hemihydrate prices
• Recent price developments of underlying feedstocks which drive the price of Levofloxacin Hemihydrate
• Market futures for both cost drives and feedstocks of Levofloxacin Hemihydrate prices
• Adjustment of current supply/demand imbalances in the Levofloxacin Hemihydrate market
• Longer term trends in likely demand conditions

What is Levofloxacin Hemihydrate and what is it used for

Levofloxacin Hemihydrate is the hemihydrate form of the active pharmaceutical ingredient of Levofloxacin, which is a broad‑spectrum third‑generation fluoroquinolone antibiotic. It acts by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby interfering with bacterial DNA replication and leading to bacterial cell death. It is used to treat a variety of bacterial infections including upper and lower respiratory tract infections, urinary tract infections (including acute pyelonephritis), skin and skin‑structure infections, and when appropriate, other serious infections caused by susceptible bacteria.

How is Levofloxacin Hemihydrate

The term “hemihydrate” refers to a crystal form of the levofloxacin molecule that includes half a molecule of water (i.e., a hydrate form), which can influence physical properties such as solubility, stability and manufacturing behaviour. In practice, levofloxacin preparations (tablets, injections) use this hemihydrate form as the API. From clinical information, levofloxacin (as API) is administered in oral or intravenous forms, depending on indication, and dosing is determined by infection type and severity.

How large is the global market for Levofloxacin Hemihydrate and where is it produced

Market‑research data indicate that the global volume market for Levofloxacin Hemihydrate (API) was around **17 000 tonnes in 2024**, and is forecast to grow to approximately **29 000 tonnes by 2035** at a compound annual growth rate (CAGR) of ~5%. Other sources quantify the API value market: one report estimates the global market size at around **US\$320 million in 2024**, increasing to roughly US\$450 million by 2033. Production of Levofloxacin Hemihydrate is concentrated in Asia‑Pacific countries — particularly India and China — where many active pharmaceutical ingredient (API) manufacturers operate. Many manufacturers listed are based in India, China and also in Europe (e.g., Spain) and export globally.